Acadian Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.21M | Buy |
623,138
+216,733
| +53% | +$2.51M | 0.01% | 495 |
|
|
2025
Q1 | $3.54M | Buy |
406,405
+254,607
| +168% | +$2.22M | 0.01% | 604 |
|
|
2024
Q4 | $2.18M | Buy |
+151,798
| New | +$2.18M | 0.01% | 745 |
|
|
2021
Q2 | – | Sell |
-178
| Closed | -$32K | – | 2218 |
|
|
2021
Q1 | $32K | Sell |
178
-1,208
| -87% | -$217K | ﹤0.01% | 1906 |
|
|
2020
Q4 | $197K | Buy |
+1,386
| New | +$197K | ﹤0.01% | 1556 |
|
|
2020
Q3 | – | Sell |
-389
| Closed | -$35K | – | 2359 |
|
|
2020
Q2 | $35K | Buy |
+389
| New | +$35K | ﹤0.01% | 2006 |
|